Medicon Valley elects new Chairman
![Foto: MVA/PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article7646305.ece/ALTERNATES/schema-16_9/S%25C3%25B8ren%2520Bregenholt%2520til%2520Escenic.jpg)
Søren Bregenholt, Corporate Vice President, External Innovation and Stakeholder Relations of Novo Nordisk, will become the new Chairman of the Board in the Danish-Swedish life science cluster Medicon Valley Alliance (MVA). He was elected for the position at the organization’s annual general assembly last week.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Medicon Valley Alliance headed for breakup
For abonnenter
AstraZeneca targets Danish partnerships
For abonnenter
Medicon Valley finally joins prestigious program
For abonnenter